• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非缺血性扩张型心肌病患者室性心律失常的复发:基于证据的预测因素。

Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors.

机构信息

Department of Cardiology, J. Brudziński Hospital, Gdynia, Poland.

出版信息

Kardiol Pol. 2009 Aug;67(8):837-44.

PMID:19784881
Abstract

BACKGROUND

Ventricular arrhythmia (VA) is the most frequent cause of sudden death among patients with non-ischaemic dilated cardiomyopathy (DCM).

AIM

To identify the important VA risk factors in patients with DCM.

METHODS AND RESULTS

Eighty-five DCM patients (73 males, mean age 54 years) with DCM and implantable cardioverter defibrillators (ICD) were followed for 21+/-19 months after ICD implantation. The mean follow-up was 21 months. Data from 55 patients with VA recorded in the ICD memory and requiring ICD intervention during follow-up were compared with 30 patients without arrhythmia. Cox regression analysis identified the following univariate predictors of VA: alcoholic aetiology of DCM (0.05), diuretic treatment (0.003), history of cardiac arrest (0.03), right ventricular diastolic diameter (0.001). Both ACE inhibitor (ACEI) and statin treatments were associated with a tendency towards decreased risk of VA. Multivariate logistic analysis identified four predictors as significantly related to VA: alcoholic aetiology (HR 4.8, p=0.008), ACEI treatment (HR 0.4, p=0.01), diuretic treatment (HR 2.6, p=0.015), and statin treatment (HR 0.1, p=0.03).

CONCLUSIONS

The majority of patients with DCM and ICD have recurrences of VA. Alcoholic aetiology of DCM is associated with an increase in the incidence of arrhythmias. Treatment with ACEI and statins is associated with a reduction of arrhythmias.

摘要

背景

室性心律失常(VA)是缺血性扩张型心肌病(DCM)患者猝死的最常见原因。

目的

确定 DCM 患者中重要的 VA 危险因素。

方法和结果

85 例 DCM 患者(73 名男性,平均年龄 54 岁),在植入埋藏式心脏复律除颤器(ICD)后,DCM 和 ICD 随访 21+/-19 个月。平均随访时间为 21 个月。比较了在随访期间记录在 ICD 记忆中的 55 例 VA 患者和 30 例无心律失常患者的 ICD 干预所需数据。Cox 回归分析确定了 VA 的以下单变量预测因素:DCM 的酒精病因(0.05),利尿剂治疗(0.003),心脏骤停史(0.03),右心室舒张直径(0.001)。ACE 抑制剂(ACEI)和他汀类药物治疗均与 VA 风险降低呈相关趋势。多变量逻辑分析确定了四个与 VA 显著相关的预测因素:酒精病因(HR 4.8,p=0.008),ACEI 治疗(HR 0.4,p=0.01),利尿剂治疗(HR 2.6,p=0.015)和他汀类药物治疗(HR 0.1,p=0.03)。

结论

大多数患有 DCM 和 ICD 的患者都有 VA 的复发。DCM 的酒精病因与心律失常发生率的增加有关。ACEI 和他汀类药物的治疗与心律失常的减少有关。

相似文献

1
Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors.非缺血性扩张型心肌病患者室性心律失常的复发:基于证据的预测因素。
Kardiol Pol. 2009 Aug;67(8):837-44.
2
Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.无再同步功能的心脏除颤器植入后患者生存率的决定因素。
Kardiol Pol. 2012;70(11):1099-110.
3
Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.导致冠心病或非缺血性扩张型心肌病患者 ICD 干预的致室性心律失常的相关因素。
Kardiol Pol. 2012;70(12):1264-75.
4
Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function.非缺血性心脏病ICD患者死亡率的长期预测因素:肾功能的影响
Europace. 2008 Sep;10(9):1052-9. doi: 10.1093/europace/eun186. Epub 2008 Aug 7.
5
Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.未接受过适当植入式心脏复律除颤器治疗的死亡:一项竞争风险研究。
Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.
6
[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].[植入式心脏复律除颤器的14年经验:预后和出院行为的判定]
Z Kardiol. 2000;89 Suppl 3:194-205.
7
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者的预防性除颤器植入
N Engl J Med. 2004 May 20;350(21):2151-8. doi: 10.1056/NEJMoa033088.
8
Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy.扩张型心肌病患者接受最佳药物治疗后的长期随访期间心脏性猝死的发生率及预测因素
Ital Heart J. 2001 Mar;2(3):213-21.
9
Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.扩张型心肌病患者预防性植入式心脏除颤器治疗的心律失常风险分层。MACAS、DEFINITE和SCD-HeFT研究结果。
Herz. 2004 May;29(3):348-52. doi: 10.1007/s00059-004-2578-0.
10
Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.扩张型心肌病中预防性植入式心脏复律除颤器治疗:左心室功能的影响
Int J Cardiol. 2006 Mar 22;108(1):26-30. doi: 10.1016/j.ijcard.2005.03.058.